Search Orphan Drug Designations and Approvals
-
| Generic Name: | A replication-incompetent, non-integrating Herpes simplex type 1 (HSV-1) vector expressing the human transglutaminase-1 (TGM-1) enzyme |
|---|---|
| Date Designated: | 08/07/2018 |
| Orphan Designation: | Treatment of TGM-1-deficient autosomal recessive congenital ichthyosis (ARCI) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Krystal Biotech, Inc. 2100 Wharton Street Pittsburgh, Pennsylvania 15203 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







